Navigation Links
ViroPharma Announces First Quarter 2013 Financial Results
Date:5/1/2013

AP net income, items such as asset impairment or upfront fees or milestone payments under license agreements, may be excluded, among others, which will be evaluated on an individual basis.

 VIROHARMA INCORPORATEDSelected Financial Information(unaudited)Selected Consolidated Balance Sheet DataMarch 31,December 31,(in thousands) 20132012AssetsCurrent assets:Cash and cash equivalents$
99,197$
75,518Short-term investments61,60771,338Inventory73,40964,384Total current assets456,829453,418Intangible assets, net503,529617,539Goodwill96,36196,759Total assets1,107,9171,219,952Liabilities and Stockholders' EquityTotal current liabilities$
,660$
4,028Deferred tax liabilities123,357167,484Long-term debt163,968161,793Total liabilities407,381462,913Total stockholders' equity700,536757,039Total liabilities and stockholders' equity1,107,9171,219,952 Three months ended March 31,March 31,Statement of Cash Flows:20132012(in thousands)Net cash provided by operating activities$
3,863$
53,311Net cash provided by investing activities8,64317,894Net cash provided by (used in) financing activities2,022(39,611) 


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ViroPharma to Participate in Two December Healthcare Investor Conferences
2. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
4. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
5. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
6. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
7. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
8. WuXi PharmaTech Announces Third-Quarter 2011 Results
9. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
10. Spherix Announces Third Quarter Financial Results
11. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 Pacific Northwest Biotechnology, LLC ... Global Markets Direct,s, ,Pacific Northwest Biotechnology, LLC ... overview of the Pacific Northwest Biotechnology, LLC,s pharmaceutical ... comprehensive information on the current therapeutic developmental pipeline ... analysis at various stages, therapeutics assessment by drug ...
(Date:9/30/2014)... 30, 2014 Proove Biosciences , ... excited to announce a new genetic test built upon ... Pain Perception Test will provide physicians with an ... pain tolerance levels are stratified between individuals. With this ... a person has a genetic predisposition that will affect ...
(Date:9/30/2014)... September 30, 2014 Genedata, ... for drug discovery and related life science ... has chosen Genedata Selector as its host-pathogen ... data. FUNGITECT is a European consortium dedicated ... diseases via individualized anti-fungal drug therapies. Genedata ...
(Date:9/30/2014)... iLab Solutions announced the results of its ... focuses on core facility operations, growth and utilization as ... , In its 4th year running, a number of ... year-over-year decrease in the percentage of revenue that comes ... the constraints of this trend. When asked, “What are ...
Breaking Biology Technology:Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3
(Date:9/30/2014)... captured the popular attention of both children and aquarium ... sold as dehydrated eggs, these tiny brine shrimp readily ... tank of salt water. , Physicists, though, are ... shrimp vertically migrate in large groups in response to ... night and retreating deeper during the day. , Two ...
(Date:9/30/2014)... Ecker, a Salk professor and Howard Hughes Medical ... have been named recipients in the 2014 round ... (NIH) through the BRAIN (Brain Research through Advancing ... The grant, announced September 30, provides more than ... over three years. , The BRAIN Initiative, launched ...
(Date:9/30/2014)... tetrachloroethylene (PCE) in drinking water may increase the ... a new study led by a Boston University ... published in the journal Environmental Health , ... among 1,766 women in Cape Cod, Ma., where ... the early 1980s by the installation of vinyl-lined ...
Breaking Biology News(10 mins):Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Salk scientists receive $3 million for BRAIN Initiative grant 2Contaminated water linked to pregnancy complications, BU study finds 2
... company spun off by The Children,s Hospital of Philadelphia, ... innovative drug delivery system using magnetically targeted nanoparticles to ... West Philadelphia, announced that Devon Park Bioventures, of Wayne, ... financing agreement. "It,s exciting to see that one ...
... tuberculosis can cause tuberculosis with as little as 10 ... to tens of millions of cells to cause cholera? This ... Institute, in France, and the Instituto Gulbenkian de Ciencia and ... issue of the journal PLoS Pathogens . The researchers ...
... The 9th annual Seena Magowitz Celebrity Golf Classic raised ... Research Institute (TGen) through the Seena Magowitz Foundation. ... run by TGen,s Pancreatic Cancer Research Team. This ... suppliers in the mattress industry longtime supporters of ...
Cached Biology News:Biotech firm spun off from Children's Hospital raises $7 million to advance vascular treatment 2Frontal attack or stealth? 2Celebrity Golf Classic raises $553,443 for Seena Magowitz Foundation 2
Phospho- (Ser) 14-3-3 Binding Motif (4E2) Mouse mAb...
Request Info...
Rabbit polyclonal to UBC12 (rating: ****) ( Abpromise for all tested applications). Antigen: Synthetic peptide: RGGYIGSTYFER, corresponding to amino acids 169-180 of UBC12 Entrez Gene ID: 90...
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Biology Products: